Amino Health Secures $10 Million in Funding Round Led by Transformation Capital to Advance Product Investments in AI Care Journeys

SAN FRANCISCO–(BUSINESS WIRE)–#AI–Amino Health, the leading digital healthcare navigation company, today announced a $10 million funding round led by Transformation Capital. The funds will be used to accelerate Amino’s AI product roadmap to build personalized patient care journeys. This latest capital infusion follows a $30M investment by Transformation Capital in May of 2023.


Amino Health’s care navigation platform simplifies the complexity of healthcare by recommending high quality healthcare providers based on objective, proprietary clinical data. Amino is the only platform that can incorporate the complexity of modern employer benefit programs.

Today, employers are faced with rising healthcare costs, complex benefit plans, and low utilization of specialized solution providers. Meanwhile employees struggle to know what is covered by their health insurance, and how to access programs available to them. Amino solves the complexity of modern healthcare plans by creating a simple consumer interface that routes more than 10K medical topics to the best provider, facility, or employer program.

Amino’s AI investments will further improve the user experience by offering personalized care recommendations based on a user’s unique care journey. In the last year alone, Amino’s Product and Clinical teams have seen the benefits of leveraging AI to generate thousands of new care topics. These new topics benefit a wider range of users and care needs, including expanded primary care, women’s health, LGBTQ+ health, more complex diseases, and specialized care for all stages of life, such as pediatric and geriatric care.

“We believe Amino Health is poised to make a transformative impact in the healthcare landscape through its innovative AI-driven approach to care navigation,” said Mike Dixon, Managing Partner at Transformation Capital. “We are excited to further invest in Amino Health, and accelerate their journey to revolutionize healthcare delivery and drive meaningful improvements in cost savings and member engagement.”

“This investment underscores the confidence placed in our vision to harness the power of AI to revolutionize healthcare. With this infusion of capital, we are poised to strengthen our AI capabilities, expand our team, and drive innovation that will shape the future of patient-centered care,” said John Asalone, Amino’s CEO.

For more information about Amino Health and its AI-powered healthcare solutions, please visit https://partners.amino.com/press.

About Amino Health

Amino Health, the leading data-driven healthcare guidance platform, connects people with high-quality, cost-effective providers and benefits programs in context across the healthcare ecosystem. With more than 30B healthcare claims used to inform our actionable healthcare recommendations, Amino Health reduces wasteful claims spending, streamlines care routing, increases care quality, and improves care outcomes for plan sponsors and members. To learn more, visit amino.com.

About Transformation Capital

Transformation Capital is a digital health growth equity firm dedicated to supporting commercial stage companies focused on improving people’s health and the sustainability of the healthcare system. The firm was founded on the premise that investing in healthcare requires both a sophisticated understanding of the healthcare system, including the prevailing market forces and resulting opportunities, as well as deep connections with decision makers across key providers, payers and digital health innovators. Transformation Capital has invested in digital health companies across the ecosystem, including Datavant, Apree, Capital RX, Health Catalyst, Sword, Grow, Jeenie and Groups.

Contacts

Media Contact for Amino Health

Lyndsey Steinbock

[email protected]

Media Contact for Transformation Capital

Melanie Albanese

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.